SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Evaxion to Present Phase 2 EVX-01 Biomarker Data at SITC 2026

Evaxion says it will present new biomarker data from its phase 2 trial of personalized cancer vaccine EVX-01 at the SITC 2026 Annual Meeting.

EVAX

Related stories